Key result
Novel LEAD2ER hybrid ablation successfully treats ventricular tachycardia using lead-mediated radiofrequency delivery and extraction.
Why the study?
Lead-mediated ventricular tachycardia involving the tip electrode region is a challenging therapeutic target and an under-recognized indication for catheter ablation and/or transvenous lead extraction.
Case Report (n=1)
Answers are grounded in this paper and cite their sources.
Describes a novel hybrid ablation approach (LEAD2ER) for the challenging therapeutic target of lead-mediated ventricular tachycardia.
Both right ventricular (RV) and left ventricular (LV) leads have been reported to induce lead-mediated ventricular tachycardia (VT). Involvement of the tip electrode region in the re-entry circuit represents a challenging therapeutic target and has been described as a rare or frequently under-recognized indication for catheter ablation (CA) and/or transvenous lead extraction (TLE) [1-3]. We present the first case of an innovative hybrid ablation approach, termed LEAD2ER, combining RV lead-mediated radiofrequency energy delivery followed by transvenous lead extraction for the treatment of ventricular tachycardia.
No takes yet. Share an insight, caveat, or question.
Stec et al. (2026) conducted a case report in Lead-mediated ventricular tachycardia (n=1). LEAD2ER approach (hybrid ablation combining RV lead-mediated radiofrequency energy delivery and transvenous lead extraction) was evaluated. A novel hybrid ablation approach (LEAD2ER) combining RV lead-mediated radiofrequency energy delivery and transvenous lead extraction was presented for treating ventricular tachycardia.
Synapse has enriched 10 related papers. Consider them for comparative context: